Anaprazole

A proton pump inhibitor used in the treatment of gastric acid-related disorders

Anaprazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Anaprazole is a proton pump inhibitor (PPI) that is used in the treatment of various conditions related to excessive gastric acid production. It is part of a class of medications that reduce stomach acid by blocking the enzyme in the wall of the stomach that produces acid.

Mechanism of Action

Anaprazole works by inhibiting the H+/K+ ATPase enzyme system, also known as the proton pump, in the gastric parietal cells. This action effectively reduces the production of gastric acid, providing relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome.

Pharmacokinetics

Anaprazole is absorbed in the small intestine and undergoes hepatic metabolism. It is primarily metabolized by the cytochrome P450 enzyme system, particularly CYP2C19 and CYP3A4. The drug is then excreted through the urine and feces.

Clinical Uses

Anaprazole is indicated for the treatment of:

• Gastroesophageal reflux disease (GERD)
• Peptic ulcer disease
• Zollinger-Ellison syndrome
• Erosive esophagitis

Side Effects

Common side effects of Anaprazole include headache, nausea, diarrhea, abdominal pain, and dizziness. Long-term use of PPIs, including Anaprazole, may be associated with an increased risk of osteoporosis-related fractures, Clostridium difficile infection, and hypomagnesemia.

Drug Interactions

Anaprazole may interact with other medications metabolized by the cytochrome P450 system. It can affect the absorption of drugs that require an acidic environment for optimal absorption, such as ketoconazole and iron supplements.

Related pages

• Proton pump inhibitor
• Gastroesophageal reflux disease
• Peptic ulcer disease
• Zollinger-Ellison syndrome